We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.53B
AUM Growth
+$98M
Cap. Flow
-$58.3M
Cap. Flow %
-1.65%
Top 10 Hldgs %
13.53%
Holding
1,397
New
118
Increased
442
Reduced
608
Closed
107

Sector Composition

Rank Sector Weight
1 Healthcare 12.97%
2 Financials 11.54%
3 Technology 10.61%
4 Industrials 9.38%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DISH
901
DELISTED
DISH Network Corp.
DISH
$383K 0.01%
6,032
-10,378
-63% -$642K
ENLC
902
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$382K 0.01%
19,700
BHC icon
903
Bausch Health
BHC
$2.57B
$379K 0.01%
34,407
+10,647
+45% +$146K
DLR icon
904
Digital Realty Trust
DLR
$69.7B
$378K 0.01%
3,554
+1,210
+52% +$127K
ANDX
905
DELISTED
Andeavor Logistics LP
ANDX
$378K 0.01%
6,942
-5,117
-42% -$284K
EZU icon
906
iShare MSCI Eurozone ETF
EZU
$9.64B
$376K 0.01%
+10,005
New +$359K
HP icon
907
Helmerich & Payne
HP
$3.45B
$376K 0.01%
+5,647
New +$402K
UAA icon
908
Under Armour
UAA
$2.84B
$375K 0.01%
19,011
-672
-3% -$15.7K
BHI
909
DELISTED
Baker Hughes
BHI
$375K 0.01%
6,264
+941
+18% +$57.3K
EFX icon
910
Equifax
EFX
$20.3B
$374K 0.01%
2,734
-125
-4% -$15.9K
GIB icon
911
CGI
GIB
$15.1B
$374K 0.01%
7,800
NRO
912
Neuberger Real Estate Securities Income Fund Inc
NRO
$191M
$370K 0.01%
72,921
+46,878
+180% +$237K
VSH icon
913
Vishay Intertechnology
VSH
$5.25B
$370K 0.01%
22,500
FCNCA icon
914
First Citizens BancShares
FCNCA
$24.9B
$369K 0.01%
1,100
LW icon
915
Lamb Weston
LW
$7.22B
$369K 0.01%
8,751
-1,306
-13% -$51.5K
SNAP icon
916
Snap
SNAP
$7.89B
$369K 0.01%
+16,369
New +$363K
GDO
917
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.1M
$367K 0.01%
21,076
+306
+1% +$5.3K
PKX icon
918
POSCO
PKX
$16.1B
$367K 0.01%
5,681
IMPV
919
DELISTED
Imperva, Inc.
IMPV
$367K 0.01%
8,950
-655
-7% -$27.3K
BSX icon
920
Boston Scientific
BSX
$69.5B
$366K 0.01%
14,757
-9,546
-39% -$232K
CTAS icon
921
Cintas
CTAS
$81.9B
$366K 0.01%
11,572
-18,800
-62% -$556K
SNDX icon
922
Syndax Pharmaceuticals
SNDX
$1.69B
$365K 0.01%
+26,594
New +$276K
NUAN
923
DELISTED
Nuance Communications, Inc.
NUAN
$365K 0.01%
24,351
-231
-0.9% -$3.29K
CLDX icon
924
Celldex Therapeutics
CLDX
$2.99B
$364K 0.01%
6,725
-1,114
-14% -$58K
NWE icon
925
NorthWestern Energy
NWE
$4.23B
$364K 0.01%
6,200

Similar funds

Oppenheimer & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Oppenheimer & Co held 1,397 positions worth $3.53B, up 2.9% from $3.44B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q1 2017 filing shows 118 new, 442 increased, 608 reduced and 107 closed positions. Its largest new stake was Robert Half: 53,601 shares worth $2.62M. The largest sale was Finish Line, an estimated $14.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q1 2017 buy was Robert Half: 53,601 shares worth $2.62M.
  • Oppenheimer & Co added most to Enbridge in Q1 2017, an estimated $9.97M increase.
  • Oppenheimer & Co's biggest Q1 2017 reduction was Finish Line, cutting an estimated $14.5M.
  • Oppenheimer & Co fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $9.83M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.53B portfolio in Q1 2017.
  • Oppenheimer & Co opened 118 new positions and closed 107 in Q1 2017.
  • Oppenheimer & Co's portfolio value rose 2.9% quarter-over-quarter to $3.53B.

Based on Oppenheimer & Co's 13F filing for Q1 2017, filed 15 May 2017.